{"id":"https://openalex.org/W2896883136","doi":"https://doi.org/10.3389/fimmu.2018.02420","title":"Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani","display_name":"Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani","publication_year":2018,"publication_date":"2018-10-17","ids":{"openalex":"https://openalex.org/W2896883136","doi":"https://doi.org/10.3389/fimmu.2018.02420","mag":"2896883136","pmid":"https://pubmed.ncbi.nlm.nih.gov/30386348","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6199377"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2018.02420","doi":"https://doi.org/10.3389/fimmu.2018.02420","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.02420","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02420/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02420/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056325210","display_name":"Malcolm S. Duthie","orcid":"https://orcid.org/0000-0002-8515-5516","observed_orcids":["https://orcid.org/0000-0002-8515-5516"]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Malcolm S. Duthie","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021503403","display_name":"Neal Van Hoeven","orcid":"https://orcid.org/0000-0002-1636-4824","observed_orcids":["https://orcid.org/0000-0002-1636-4824"]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal Van Hoeven","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060202479","display_name":"Zachary MacMillen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary MacMillen","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000819032","display_name":"Alessandro Picone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alessandro Picone","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081638166","display_name":"Raodoh Mohamath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raodoh Mohamath","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021777037","display_name":"Jesse H. Erasmus","orcid":"https://orcid.org/0000-0003-1612-2697","observed_orcids":["https://orcid.org/0000-0003-1612-2697"]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jesse Erasmus","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035057031","display_name":"Fan\u2010Chi Hsu","orcid":"https://orcid.org/0000-0001-5366-2671","observed_orcids":["https://orcid.org/0000-0001-5366-2671"]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fan-Chi Hsu","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028413988","display_name":"Dan T. Stinchcomb","orcid":"https://orcid.org/0000-0002-3634-7503","observed_orcids":["https://orcid.org/0000-0002-3634-7503"]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan T. Stinchcomb","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069585538","display_name":"Steven G. Reed","orcid":"https://orcid.org/0000-0003-2193-100X","observed_orcids":["https://orcid.org/0000-0003-2193-100X"]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven G. Reed","raw_affiliation_strings":["Infectious Disease Research Institute, Seattle, WA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Research Institute, Seattle, WA, United States","institution_ids":["https://openalex.org/I1330732676"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5056325210"],"corresponding_institution_ids":["https://openalex.org/I1330732676"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":2614,"currency":"EUR","value_usd":2819},"fwci":4.2016,"has_fulltext":true,"cited_by_count":65,"citation_normalized_percentile":{"value":0.94451898,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"9","issue":null,"first_page":"2420","last_page":"2420"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leishmaniasis","display_name":"leishmaniasis","score":0.9549999833106995},{"id":"https://openalex.org/keywords/leishmania-donovani","display_name":"Leishmania donovani","score":0.996999979019165},{"id":"https://openalex.org/keywords/rna-vaccines","display_name":"RNA vaccines","score":0.7829999923706055},{"id":"https://openalex.org/keywords/heterologous-prime-boost-vaccination","display_name":"heterologous prime-boost","score":0.8569999933242798},{"id":"https://openalex.org/keywords/protein-subunit-vaccines","display_name":"subunit vaccine","score":0.9269999861717224},{"id":"https://openalex.org/keywords/cd4-t-cell-responses","display_name":"CD4+ T cell responses","score":0.7889999747276306},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.9990000128746033},{"id":"https://openalex.org/keywords/t-helper-1-response","display_name":"T helper 1 response","score":0.8650000095367432},{"id":"https://openalex.org/keywords/toll-like-receptor-4-agonist","display_name":"Toll-like receptor 4 agonist","score":0.8209999799728394},{"id":"https://openalex.org/keywords/antigen-presenting-cells","display_name":"antigen-presenting cells","score":0.9359999895095825},{"id":"https://openalex.org/keywords/canine-leishmaniasis","display_name":"canine leishmaniasis","score":0.8259999752044678},{"id":"https://openalex.org/keywords/intracellular-pathogens","display_name":"intracellular pathogens","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5808761715888977},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5712018609046936},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5507843494415283},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.45139193534851074},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.44211000204086304},{"id":"https://openalex.org/C2780115692","wikidata":"https://www.wikidata.org/wiki/Q5747302","display_name":"Heterologous","level":3,"score":0.4342010021209717},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.41542285680770874},{"id":"https://openalex.org/C2781333301","wikidata":"https://www.wikidata.org/wiki/Q1950752","display_name":"Leishmania donovani","level":4,"score":0.4128098487854004},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4114239811897278},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4097934067249298},{"id":"https://openalex.org/C2776555147","wikidata":"https://www.wikidata.org/wiki/Q331283","display_name":"Leishmaniasis","level":2,"score":0.24760860204696655},{"id":"https://openalex.org/C2778689377","wikidata":"https://www.wikidata.org/wiki/Q2046113","display_name":"Visceral leishmaniasis","level":3,"score":0.21428877115249634},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06110036373138428},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.05796661972999573},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05315679311752319}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007117","descriptor_name":"Immunization, Secondary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007893","descriptor_name":"Leishmania donovani","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007893","descriptor_name":"Leishmania donovani","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":true},{"descriptor_ui":"D007898","descriptor_name":"Leishmaniasis, Visceral","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D021381","descriptor_name":"Protein Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051199","descriptor_name":"Toll-Like Receptor 7","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054332","descriptor_name":"Leishmaniasis Vaccines","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D054332","descriptor_name":"Leishmaniasis Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D064789","descriptor_name":"Immunity, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2018.02420","doi":"https://doi.org/10.3389/fimmu.2018.02420","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.02420","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02420/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5159401","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6199377","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6199377","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6199377","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:30386348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30386348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:bc3991382b6748c69bbe020ab7fd195d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/bc3991382b6748c69bbe020ab7fd195d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 9 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2018.02420","doi":"https://doi.org/10.3389/fimmu.2018.02420","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.02420","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.02420/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3784061086","display_name":"Leishmania antigens defined by human immune responses","funder_award_id":"R01AI025038","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7403774520","display_name":"Development of a novel replicating viral RNA vaccine platform","funder_award_id":"F32AI136371","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7519670736","display_name":null,"funder_award_id":"HHSN272201600036C","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G8113723440","display_name":null,"funder_award_id":"R01AI025038","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"}],"funders":[{"id":"https://openalex.org/F4320306137","display_name":"Bill and Melinda Gates Foundation","ror":"https://ror.org/0456r8d26"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2896883136.pdf","grobid_xml":"https://content.openalex.org/works/W2896883136.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W201991790","https://openalex.org/W1552315819","https://openalex.org/W1590082526","https://openalex.org/W1855484651","https://openalex.org/W1958722027","https://openalex.org/W1964200211","https://openalex.org/W1964509000","https://openalex.org/W1972018312","https://openalex.org/W1974485086","https://openalex.org/W1976218763","https://openalex.org/W1981816112","https://openalex.org/W1982091532","https://openalex.org/W1994674548","https://openalex.org/W2014992495","https://openalex.org/W2016570101","https://openalex.org/W2020711392","https://openalex.org/W2026286437","https://openalex.org/W2051665875","https://openalex.org/W2056004964","https://openalex.org/W2075870137","https://openalex.org/W2085342350","https://openalex.org/W2086101311","https://openalex.org/W2091572022","https://openalex.org/W2094845525","https://openalex.org/W2096039130","https://openalex.org/W2099408858","https://openalex.org/W2107079403","https://openalex.org/W2109477786","https://openalex.org/W2125740219","https://openalex.org/W2127384841","https://openalex.org/W2127622784","https://openalex.org/W2128488216","https://openalex.org/W2129971483","https://openalex.org/W2155423122","https://openalex.org/W2159661415","https://openalex.org/W2419348795","https://openalex.org/W2548622446","https://openalex.org/W2584249987","https://openalex.org/W2586729406","https://openalex.org/W2587850379","https://openalex.org/W2597052561","https://openalex.org/W2738515079","https://openalex.org/W2748575259","https://openalex.org/W2777009493","https://openalex.org/W2887139475"],"related_works":["https://openalex.org/W2478346411","https://openalex.org/W1972018312","https://openalex.org/W2128497647","https://openalex.org/W1986640849","https://openalex.org/W2027429905","https://openalex.org/W1964509000","https://openalex.org/W1995543014","https://openalex.org/W2080262260","https://openalex.org/W1993178419","https://openalex.org/W2095331802"],"abstract_inverted_index":{"The":[0],"rapid":[1],"generation":[2,162],"of":[3,105,116,131,154,172,207,215],"strong":[4],"T":[5,19,27,39,78,144,181,221],"cell":[6,28,40,79,182,222],"responses":[7,41,80,126,148,223],"is":[8],"also":[9,178],"highly":[10],"desirable":[11],"and":[12,59,93,133,219],"viral":[13],"vectors":[14],"can":[15],"have":[16,49],"potent":[17,142,216],"CD8+":[18],"cell-inducing":[20],"activity.":[21],"Immunity":[22],"to":[23,110,138],"leishmaniasis":[24,52,92,98],"requires":[25],"selective":[26],"responses,":[29],"with":[30,68,118,152,160,185,198],"immunization":[31,176,210],"schemes":[32,211],"that":[33,61,127],"raise":[34],"either":[35,153],"CD4":[36,218],"or":[37],"CD8":[38,220],"being":[42],"protective":[43,76],"in":[44,64,81,90,94,97,166,174],"small":[45],"animal":[46,82],"models.":[47],"We":[48,100],"defined":[50],"the":[51,102,119,155,175,205,213],"vaccine":[53,108,113,188,193],"candidate":[54],"recombinant":[55],"fusion":[56],"antigens,":[57],"LEISH-F2":[58],"LEISH-F3+,":[60],"when":[62],"formulated":[63],"a":[65,69],"stable":[66,167],"emulsion":[67],"Toll-like":[70],"receptor":[71],"(TLR)":[72],"4":[73],"agonist":[74],"induce":[75],"CD4+":[77],"models,":[83],"as":[84,86],"well":[85],"providing":[87],"therapeutic":[88],"efficacy":[89],"canine":[91],"clinical":[95],"trials":[96],"patients.":[99],"used":[101],"genetic":[103],"sequences":[104],"these":[106,202],"validated":[107],"antigens":[109],"design":[111],"RNA":[112,120,173,187],"constructs.":[114],"Immunization":[115,184],"mice":[117],"replicons":[121],"induced":[122],"potent,":[123],"local":[124],"innate":[125],"were":[128],"surprisingly":[129],"independent":[130],"TLR7":[132],"activated":[134],"antigen-presenting":[135],"cells":[136],"(APC)":[137],"prime":[139],"for":[140,212,224],"extremely":[141],"antigen-specific":[143,217],"helper":[145],"1":[146],"type":[147],"upon":[149],"heterologous":[150,208],"boosting":[151],"subunit":[156,192],"vaccines":[157],"(recombinant":[158],"antigen":[159],"second":[161],"glucopyranosyl":[163],"lipid":[164],"A":[165],"oil-in-water":[168],"emulsion;":[169],"SLA-SE).":[170],"Inclusion":[171],"schedule":[177],"generated":[179],"MHCI-restricted":[180],"responses.":[183],"LEISH-F2-expressing":[186],"followed":[189],"later":[190],"by":[191],"afforded":[194],"protection":[195,225],"against":[196,226],"challenge":[197],"Leishmania":[199],"donovani.":[200],"Together,":[201],"data":[203],"indicate":[204],"utility":[206],"prime-boost":[209],"induction":[214],"intracellular":[227],"pathogens.":[228]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-10-26T00:00:00"}